High expression level of OCT4 is related to poor prognosis in bladder cancer [126, 127], prostate cancer [128], medulloblastoma [129], esophageal squamous cell carcinoma [130], leukemia, and cancers of the ovaries, testicles, and pancreas [18]. This evidence concerns the gene POU5F1 and urinary bladder carcinoma.